1 day Ago By ABMN Staff
Agilent Technologies, Inc. ( NYSE:A – Get Free Report ) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 3,160,000 shares, an increase of 10.
5% from the August 15th total of 2,860,000 shares. Based on an average trading volume of 1,900,000 shares, the days-to-cover ratio is presently 1.7 days.
Approximately 1.1% of the company’s shares are sold short. Wall Street Analyst Weigh In A number of research analysts have recently issued reports on the company.
Bank of America lifted their price target on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd.
Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 target price (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd.
Wells Fargo & Company began coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target on the stock.
JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $165.00 to $155.
00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th.
One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $141.
60. Check Out Our Latest Analysis on A Insider Activity at Agilent Technologies Institutional Investors Weigh In On Agilent Technologies Several institutional investors have recently bought and sold shares of A. Vanguard Group Inc.
lifted its stake in shares of Agilent Technologies by 18.2% in the first quarter. Vanguard Group Inc.
now owns 29,884,345 shares of the medical research company’s stock worth $4,348,471,000 after buying an additional 4,605,228 shares in the last quarter. Norges Bank purchased a new position in Agilent Technologies in the 4th quarter worth approximately $509,904,000. Price T Rowe Associates Inc.
MD boosted its holdings in shares of Agilent Technologies by 13.9% during the 1st quarter. Price T Rowe Associates Inc.
MD now owns 8,542,054 shares of the medical research company’s stock worth $1,242,956,000 after purchasing an additional 1,042,926 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Agilent Technologies by 5.
7% in the second quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock valued at $1,952,832,000 after purchasing an additional 809,149 shares in the last quarter.
Finally, Meritage Group LP increased its holdings in shares of Agilent Technologies by 28.3% in the fourth quarter. Meritage Group LP now owns 2,116,862 shares of the medical research company’s stock valued at $294,307,000 after purchasing an additional 467,451 shares during the last quarter.
87.42% of the stock is currently owned by institutional investors and hedge funds. Agilent Technologies Stock Performance Shares of A traded up $0.
66 during trading hours on Wednesday, hitting $139.01. The stock had a trading volume of 1,351,503 shares, compared to its average volume of 1,715,516.
The firm has a market capitalization of $40.56 billion, a price-to-earnings ratio of 32.71, a PEG ratio of 6.
43 and a beta of 1.05. The company has a debt-to-equity ratio of 0.
36, a quick ratio of 1.37 and a current ratio of 1.78.
The firm has a 50-day moving average price of $137.26 and a 200 day moving average price of $139.25.
Agilent Technologies has a fifty-two week low of $96.80 and a fifty-two week high of $155.35.
Agilent Technologies ( NYSE:A – Get Free Report ) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.
26 by $0.06. The company had revenue of $1.
58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.
26% and a net margin of 21.75%. Agilent Technologies’s quarterly revenue was down 5.
6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.43 EPS.
As a group, research analysts anticipate that Agilent Technologies will post 5.24 EPS for the current year. About Agilent Technologies ( Get Free Report ) Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. Further Reading Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.
com's FREE daily email newsletter ..
